Microsoft India on Monday announced the availability of Surface Pro 6 and Surface Laptop 2 on Amazon India, Flipkart and retail stores at a starting price of Rs 83,999 and Rs 91,999 respectively.
The devices will be available for commercial or enterprise customers through authorised resellers, the company said in a statement.
“For users seeking to make new breakthroughs in 2019, Surface will be a perfect companion to bring their innovative ideas and thinking to life,” Priyadarshi Mohapatra, Country General Manager-Consumer and Devices, Microsoft India, said in a statement.
Surface Pro 6 features redesigned architecture under the hood and also combines quad-core, 8th Generation Intel Core processor.
It is 1.5 times faster than its predecessor, while offering the same all-day battery life, the company claimed.
Surface Pro 6 features a 12.3-inch “PixelSense” display that is capable of for rendering designs on photo editing software or for binge-watching series on your favourite streaming apps.
The new Surface Laptop 2 comes with improved speed and performance enabled by the 8th Generation Intel Quad Core processor; the device is 85 per cent more powerful than its predecessor, the company said.
With up to 14.5 hours of battery life, the Surface Laptop 2 comes with premium design, “PixelSense Touch Display”, and best-in-class keyboard and trackpad. (IANS)
With the Union Cabinet directing a blanket ban on e-cigarettes in the country with complete suspension of their manufacturing, import, export, distribution and storage, physicians welcomed the step while e-cigarette traders expressed shock and anger over the decision.
“Although, e-cigarettes are little less lethal then the conventional cigarettes, we cannot shun away the fact that it contains harmful ingredients. These chemicals can potentially affect the lungs and overall health of the individual in the long run,” Rajesh Chawla, Senior Pulmonologist at Indraprastha Apollo Hospital in New Delhi, told IANS.
Industry body TRENDS which represents importers, distributors and marketers of ENDS, or Electronic Nicotine Delivery Systems in India, termed the decision to ban e-cigarettes “ironic and erratic”.
“This ban on e-cigarettes on the basis of ‘selective sourcing of scientific and medical opinion’ and without holding a single stakeholder meeting is nothing short of a complete murder of democratic norms,” said Praveen Rikhy, Convenor, TRENDS (Trade Representatives of ENDS).
“All our representations sharing best practices from other countries – 70 developed countries have allowed regulated sale of e-cigarettes, have been completely ignored. We will now initiate a formal campaign to help MPs understand the issue, clarify misapprehensions and misinformation spread by lobby groups and support the farmer groups who see the growth of the e-cigarette sector as a global market opportunity for nicotine,” Rikhy said.
While e-cigarettes have been marketed as a way for adults to quit conventional smoking, a recent outbreak of lung illness associated with use of vaping products in the US has raised concerns about the safety of these products.
The Donald Trump administration on September 12 said that it plans to ban the sale of non-tobacco-flavoured e-cigarettes in the US following six deaths linked to vaping.
Health authorities have documented a total of 450 cases involving e-cigarettes, according to the US Centers for Disease Control and Prevention (CDC), which issued a health warning against vaping.
“I entirely support the idea of a ban on e-cigarettes; it is a step in the right direction,” Manoj Luthra, CEO, Jaypee Hospital in Noida, told IANS.
“E-cigarettes have been projected as a means to help people to quit smoking tobacco and also being non-polluting. However, these have their own health hazards and are addictive as well. These contain nicotine and other chemical vapours which will certainly have ill effects on the heart and lung and other organs as well,” he said. (IANS)